Skip to main content
. 2018 Oct 25;137(1):75–81. doi: 10.1001/jamaophthalmol.2018.5132

Figure 1. Actuarial Event Rate Curve for Metastasis in 18 Patients After Posterior Uveal Melanoma Treatment.

Figure 1.

Median survival, 9.0 years (95% CI, 7.6-10.4 years; 95% CI around the cumulative probability of 50%: z score, 0.23-0.77).